Company Filing History:
Years Active: 2008-2018
Title: The Innovations of Walt Mahoney
Introduction
Walt Mahoney is a notable inventor based in Woodinville, Washington. He has made significant contributions to the field of molecular biology, particularly in the detection of bacterial pathogens. With a total of seven patents to his name, Mahoney's work has advanced the methods used to identify and amplify nucleic acids related to serious infections.
Latest Patents
Mahoney's latest patents focus on innovative methods for amplifying and detecting Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) nucleic acids. These methods utilize a combined detection approach, identifying ldh1 as a marker for SA and mecA for MRSA. The patents also describe techniques for amplifying and detecting various SCCmec integration sites or bridge regions. The primers and probes developed in these methods allow for simultaneous detection of SA and MRSA in a single reaction or in separate reactions. The amplified nucleic acids can be detected using advanced techniques, including fluorescence resonance energy transfer (FRET), radiolabels, and enzyme labels.
Career Highlights
Throughout his career, Mahoney has worked with several prominent companies in the biotechnology sector. Notable among these are Elitechgroup B.V. and Epoch Biosciences, Inc. His experience in these organizations has contributed to his expertise in developing innovative detection methods for bacterial pathogens.
Collaborations
Mahoney has collaborated with esteemed colleagues in his field, including Nicolaas M. J. Vermeulen and Irina Aleksandrovna Afonina. These partnerships have further enriched his research and development efforts.
Conclusion
Walt Mahoney's contributions to the field of molecular biology through his patents and collaborations have significantly impacted the detection of bacterial infections. His innovative methods continue to advance the capabilities of pathogen detection, showcasing the importance of his work in healthcare.